The European Commission and Moderna have reached a new agreement to better address member states' needs for Covid-19 vaccines for the late summer and winter season. In this way, member states will have access to...
The European Medicines Agency (EMA) announced today that it has started the rolling evaluation of a variant-adapted Covid-19 vaccine from Pfizer and BioNTech.
The bivalent (or bivalent) vaccine targets two strains of the SARS-CoV-2 virus that causes...
Pfizer Inc and BioNTech SE announced today that they have initiated mid-level trials of a modified Covid-19 vaccine that targets both the original variants and the BA.2 Omicron sub-variant.
The vaccine is in an initial proof-of-concept study...
The European Medicines Agency (EMA) said today it has approved the use of a smallpox vaccine in humans to expand its use against the spread of monkeypox, which could mark the WHO's highest alert level.
The EMA's...
Germany's BioNTech, a Pfizer partner in Covid-19 vaccines, has announced that the two companies will begin testing next-generation vaccines in humans in the second half of the year that protect against a wide variety of coronaviruses.
Their...
Biotechnology company Moderna has announced positive preliminary results for a modified version of its Omicron variant vaccine.
A booster dose of 50 micrograms resulted in "a greater response of antibodies against the Omicron variant, one month after...
